Trinity Capital, an international alternative asset manager, announced a $35 million commitment in growth capital to Monteris Medical, a MedTech company focused on minimally invasive neurosurgical technology.
Monteris Medical develops and commercializes the NeuroBlate System, a robotically controlled laser interstitial thermal therapy (LITT) platform that uses MRI-guided laser technology to remove abnormal brain tissue. The system precisely delivers laser energy through robotic control and is used to treat brain tumors, radiation necrosis, and drug-resistant epilepsy.
The NeuroBlate System is designed as a minimally invasive alternative to traditional open brain surgery, with the goal of reducing complications and shortening hospital stays. The technology enables surgeons to target abnormal tissue with high precision while minimizing disruption to surrounding brain structures.
The $35 million financing will support Monteris Medical’s commercialization of the NeuroBlate System and help expand the company’s clinical research programs. The funding will also help accelerate the company’s growth strategy as it continues expanding the adoption of its neurosurgical platform across neuroscience centers.
Trinity Capital invests in growth-stage companies through private credit solutions across several lending verticals, including sponsor finance, equipment finance, tech lending, asset-based lending, and life sciences. Since its founding in 2008, the firm has deployed more than $5.5 billion across over 463 investments.
KEY QUOTES:
“We believe Monteris is advancing innovation across the life sciences sector with technology that is expanding treatment options in neurosurgery. We are proud to support a team that is not only pushing the boundaries of medical technology, but also delivering meaningful new treatment options for patients.”
Rob Lake, Senior Managing Director, Life Sciences at Trinity Capital
“Securing this new credit facility from Trinity Capital, alongside the support of our Series E equity investors, strengthens our ability to accelerate growth and continue delivering innovative, minimally invasive neurosurgical solutions for patients in need. Trinity’s partnership reflects strong confidence in our strategy, the NeuroBlate System, and the expanding clinical impact our technology is making across leading neuroscience centers. This financing ensures we can further invest in commercial expansion, product innovation, and the teams who bring our mission to life every day.”
Martin J. Emerson, President And CEO Of Monteris Medical
